PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Researchers identify ‘switch’ to activate cancer cell death

Researchers identify ‘switch’ to activate cancer cell death
2023-10-24
(Press-News.org) A research team from the UC Davis Comprehensive Cancer Center has identified a crucial epitope (a protein section that can activate the larger protein) on the CD95 receptor that can cause cells to die. This new ability to trigger programmed cell death could open the door for improved cancer treatments. The findings were published Oct. 14 in the Nature journal Cell Death & Differentiation.

CD95 receptors, also known as Fas, are called death receptors. These protein receptors reside on cell membranes. When activated, they release a signal that causes the cells to self-destruct.

Modulating Fas may also extend the benefits of chimeric antigen receptor (CAR) T-cell therapy to solid tumors like ovarian cancer.

“We have found the most critical epitope for cytotoxic Fas signaling, as well as CAR T-cell bystander anti-tumor function,” said Jogender Tushir-Singh, an associate professor in the Department of Medical Microbiology and Immunology and senior author of the study.

“Previous efforts to target this receptor have been unsuccessful. But now that we’ve identified this epitope, there could be a therapeutic path forward to target Fas in tumors,” Tushir-Singh said.                                                                        

Finding better cancer therapies

Cancer is generally managed with surgery, chemotherapy and radiotherapy. These treatments may work initially, but in some cases, therapy-resistant cancers often return. Immunotherapies, such as CAR T-cell-based immune therapies and immune checkpoint receptor molecule activating antibodies, have shown tremendous promise to break this cycle. But they only help an extremely small number of patients, especially in solid tumors such as ovarian, triple-negative breast cancer, lung and pancreas.

T cells are a type of immune cells. CAR T-cell therapies involve engineering patient T cells by grafting them with a specific tumor-targeting antibody to attack tumors. These engineered T cells have shown efficacy in leukemia and other blood cancers but have failed repeatedly to provide success against solid tumors. The reason is that tumor microenvironments are good at keeping T cells and other immune cells at bay.

“These are often called cold tumors because immune cells simply cannot penetrate the microenvironments to provide a therapeutic effect,” said Tushir-Singh. “It doesn’t matter how well we engineer the immune receptor activating antibodies and T cells if they cannot get close to the tumor cells. Hence, we need to create spaces so T cells can infiltrate.”

Death receptors do precisely what their name implies — when targeted, they trigger programmed cell death of tumor cells. They offer a potential workaround that could simultaneously kill tumor cells and pave the way for more effective immunotherapies and CAR T-cell therapy.

Developing drugs that boost death receptor activity could provide an important weapon against tumors. However, though drug companies have had some success targeting the Death Receptor-5, no Fas agonists have made it into clinical trials. These findings could potentially change that.

The right target

While Fas plays an essential role in regulating immune cells, Tushir-Singh and his colleagues knew they might be able to target cancer cells selectively if they found the right epitope. Having identified this specific epitope, he and other researchers can now design a new class of antibodies to selectively bind to and activate Fas to potentially destroy tumor cells specifically.

Other research in animal models and human clinical trials has shown that Fas signaling is fundamental to CAR T success, particularly in tumors that are genetically heterogeneous. Genetically heterogeneous tumors have a mix of different cell types, which can respond differently to treatment.

A Fas agonist could generate a CAR-T bystander effect, in which the treatment destroys cancer cells that lack the molecule the tumor-targeting antibody is designed to hit. In other words, activating Fas may destroy cancer cells and improve CAR T efficacy, a potential one-two punch against tumors.

In fact, the study showed tumors with a mutated version of the epitope of Fas receptors will not respond to CAR T at all. This finding could lead to new tests to identify which patients will benefit most from CAR T-cell immunotherapy.

“We should know a patient’s Fas status — particularly the mutations around the discovered epitope — before even considering giving them CAR T,” Tushir-Singh said. “This is a definitive marker for bystander treatment efficacy of CAR T therapy. But most importantly, this sets the stage to develop antibodies that activate Fas, selectively kill tumor cells, and potentially support CAR T-cell therapy in solid tumors.”

Additional authors include Tanmoy Mondal, Himanshu Gaur, Brice E. N. Wamba, Abby Grace Michalak, Camryn Stout, Matthew R. Watson, Sophia L. Aleixo, Arjun Singh, Roland Faller, Gary Scott Leiserowitz and Sanchita Bhatnagar from UC Davis. and Salvatore Condello from Indiana University School of Medicine.

Resources

Read the study Jogender Tushir-Singh Additional research (PubMed) END

[Attachments] See images for this press release:
Researchers identify ‘switch’ to activate cancer cell death Researchers identify ‘switch’ to activate cancer cell death 2 Researchers identify ‘switch’ to activate cancer cell death 3

ELSE PRESS RELEASES FROM THIS DATE:

Role of innate immunity in SARS-CoV-2 infection

2023-10-24
https://doi.org/10.1016/j.bsheal.2023.08.005   During severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, activated macrophages, dendritic cells, neutrophils, and natural killer cells are the first defense against infection. These immune effectors trap and ingest the virus, kill infected epithelial cells, or produce anti-viral cytokines. Evidence suggests that aging, obesity, and mental illness can lead to weakened innate immunity and, thus, are all associated with elevated infection and severe disease progression of coronavirus disease 2019 (COVID-19). ...

Viral rebound and safety of nirmatrelvir/ritonavir for lung-transplant recipients infected with SARS-CoV-2

2023-10-24
https://doi.org/10.1016/j.bsheal.2023.08.004   Data on the viral rebound and safety of nirmatrelvir/ritonavir in lung transplant (LTx) recipients are limited. The study prospectively followed four LTx recipients. Clinical characteristics, viral RNA dynamic in throat swabs, and tacrolimus blood concentration were monitored regularly. All four LTx recipients, aged 35–74 years, were not vaccinated against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). They got coronavirus disease 2019 (COVID-19) after ...

Residents unprepared for wildland fires, face barriers in implementing prevention measures: York U study

2023-10-23
TORONTO, October 23, 2023 –This year, Canada saw the worst wildfire season in its history, with fires destroying homes, displacing thousands of residents, and burning the largest area since contemporary records began in 1983. Much of this damage to communities could be reduced with better wildfire preparedness – but wildland urban interface (WUI) communities often face significant barriers in implementing these improvements, according to a study by York University’s Disaster and Emergency Management researchers. According to the study, Determinants of residential wildfire mitigation uptake: A ...

Diffraction-limited visible imaging for large aperture telescopes: development and application of piezoelectric deformable secondary mirror

Diffraction-limited visible imaging for large aperture telescopes: development and application of piezoelectric deformable secondary mirror
2023-10-23
A new publication from Opto-Electronic Advances, 10.29026/oea.2023.230039 discusses diffraction-limited visible imaging for large aperture telescopes.   The deformable mirror used in adaptive optics can change its surface to instantly correct the static wavefront aberration of the optical system and atmospheric turbulence wavefront disturbance. This allows the optical system to automatically adapt to changes in the environment and maintain optimal performance. High-resolution astronomical observation, laser atmospheric transmission, and biomedical imaging all make extensive use ...

Texas A&M joins multimillion-dollar moon orbit tracking project

2023-10-23
Texas A&M University is joining a multi-university team on a major research project to track objects orbiting the moon. The Air Force Research Laboratory is awarding up to $5 million over five years for the Space University Research Initiative (SURI). “The SURI is an outstanding initiative to train our next-generation workforce. We look forward to carrying out creative research aimed at addressing astronautical challenges in cislunar space,” said Dr. Manoranjan Majji, an associate professor and Josey Family Foundation Faculty Fellow in the Department of Aerospace Engineering at ...

Nurse practitioners and physicians are similarly likely to inappropriately prescribe medications to older patients

2023-10-23
Embargoed for release until 5:00 p.m. ET on Monday 23 October 2023 Annals of Internal Medicine Tip Sheet @Annalsofim Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of information. This information is under strict embargo and by taking it into possession, media representatives are committing to the terms of the embargo not only on their own behalf, but also on behalf of the organization ...

UArizona researchers probe how a piece of the moon became a near-Earth asteroid

UArizona researchers probe how a piece of the moon became a near-Earth asteroid
2023-10-23
In 2021, a team of University of Arizona astronomers suggested that a recently discovered near-Earth asteroid, Kamo`oalewa, could be a chunk of the moon. Two years after the striking discovery, another UArizona research group has found that a rare pathway could have enabled this to happen. So far, only distant asteroids from beyond the orbit of Mars have been considered a source of near-Earth asteroids, said Renu Malhotra, Regents Professor of Planetary Sciences and a senior author on the paper. "We are now establishing that the moon is a more likely source ...

Rare lungs cells reveal another surprise with implications for cystic fibrosis

Rare lungs cells reveal another surprise with implications for cystic fibrosis
2023-10-23
A new study by University of Iowa researchers finds that rare lung cells known as pulmonary ionocytes facilitate the absorption of water and salt from the airway surface. This function is exactly the opposite of what was expected of these cells and may have implications for cystic fibrosis (CF) lung disease.   Five years ago, scientists reported the unexpected discovery that ionocytes—a cell type commonly found in fish gills and frog skin—are also present in the lining of human lungs and airways. These pulmonary ionocytes were particularly interesting to CF researchers because although they only account for about 1% of all the cells in the airway ...

New UCF project is harnessing virtual reality to teach quantum computing

2023-10-23
ORLANDO, Oct. 23, 2023 – Researchers from the University of Central Florida, University of Texas at Dallas and Vanderbilt University have received a three-year, $927,203 grant for advancing future quantum education by using virtual reality (VR) and machine learning to identify and address misconceptions regarding quantum information science (QIS). The U.S. National Science Foundation-funded project started in August 2023 and leverages QubitVR, a quantum-education VR application previously developed ...

Major pathologic response to neoadjuvant pembrolizumab in advanced melanoma trial exceeds 50 percent

2023-10-23
In exploratory analyses of results from the SWOG S1801 trial in patients with stage III-IV resectable melanoma, researchers saw a major pathologic response in more than half of surgical specimens taken from patients who had been treated with neoadjuvant (pre-operative) pembrolizumab. These and other results of the analyses are presented as a proffered paper (Abstract LBA48) at the European Society of Medical Oncology (ESMO) Congress 2023 in Madrid, Spain, on Monday, October 23, by Sapna P. Patel, MD, chair of the SWOG melanoma committee and associate professor of melanoma medical oncology at the University of Texas MD Anderson Cancer Center. Patel is principal investigator ...

LAST 30 PRESS RELEASES:

Exercise as an anti-ageing intervention to avoid detrimental impact of mental fatigue

UMass Amherst Nursing Professor Emerita honored as ‘Living Legend’

New guidelines aim to improve cystic fibrosis screening

Picky eaters by day, buffet by night: Butterfly, moth diets sync to plant aromas

Pennington Biomedical’s Dr. Leanne Redman honored with the E. V. McCollum Award from the American Society for Nutrition

CCNY physicists uncover electronic interactions mediated via spin waves

Researchers’ 3D-printing formula may transform future of foam

Nurture more important than nature for robotic hand

Drug-delivering aptamers target leukemia stem cells for one-two knockout punch

New study finds that over 95% of sponsored influencer posts on Twitter were not disclosed

New sea grant report helps great lakes fish farmers navigate aquaculture regulations

Strain “trick” improves perovskite solar cells’ efficiency

How GPS helps older drivers stay on the roads

Estrogen and progesterone stimulate the body to make opioids

Dancing with the cells – how acoustically levitating a diamond led to a breakthrough in biotech automation

Machine learning helps construct an evolutionary timeline of bacteria

Cellular regulator of mRNA vaccine revealed... offering new therapeutic options

Animal behavioral diversity at risk in the face of declining biodiversity

Finding their way: GPS ignites independence in older adult drivers

Antibiotic resistance among key bacterial species plateaus over time

‘Some insects are declining but what’s happening to the other 99%?’

Powerful new software platform could reshape biomedical research by making data analysis more accessible

Revealing capillaries and cells in living organs with ultrasound

American College of Physicians awards $260,000 in grants to address equity challenges in obesity care

Researchers from MARE ULisboa discover that the European catfish, an invasive species in Portugal, has a prolonged breeding season, enhancing its invasive potential

Rakesh K. Jain, PhD, FAACR, honored with the 2025 AACR Award for Lifetime Achievement in Cancer Research

Solar cells made of moon dust could power future space exploration

Deporting immigrants may further shrink the health care workforce

Border region emergency medical services in migrant emergency care

Resident physician intentions regarding unionization

[Press-News.org] Researchers identify ‘switch’ to activate cancer cell death